| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.37B | 126.67B | 125.92B | 124.83B | 105.95B | 116.60B |
| Gross Profit | 33.60B | 33.28B | 31.46B | 29.35B | 25.34B | 26.01B |
| EBITDA | 14.17B | 12.79B | 11.04B | 9.96B | 7.25B | 7.19B |
| Net Income | 7.50B | 6.91B | 5.47B | 4.73B | 2.92B | 3.17B |
Balance Sheet | ||||||
| Total Assets | 149.26B | 151.54B | 154.98B | 147.00B | 141.11B | 135.87B |
| Cash, Cash Equivalents and Short-Term Investments | 21.89B | 15.73B | 19.37B | 20.33B | 21.36B | 20.42B |
| Total Debt | 20.12B | 20.42B | 15.04B | 21.56B | 24.29B | 22.85B |
| Total Liabilities | 61.65B | 62.86B | 72.25B | 74.03B | 73.49B | 70.75B |
| Stockholders Equity | 86.62B | 87.69B | 81.74B | 71.61B | 66.34B | 63.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.69B | 7.90B | 2.69B | 325.00M | 1.64B |
| Operating Cash Flow | 0.00 | -2.34B | 10.28B | 5.06B | 2.81B | 5.91B |
| Investing Cash Flow | 0.00 | -3.57B | -2.69B | -1.74B | -2.46B | -4.03B |
| Financing Cash Flow | 0.00 | 2.19B | -8.60B | -4.50B | 482.00M | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥756.15B | 9.48 | 10.78% | 4.68% | -1.97% | 47.63% | |
78 Outperform | ¥97.60B | 10.00 | ― | 3.92% | 1.06% | 45.19% | |
74 Outperform | ¥349.57B | 12.83 | ― | 3.26% | -7.77% | 58.84% | |
74 Outperform | ¥386.13B | 9.05 | 6.16% | 2.99% | -0.02% | -40.45% | |
74 Outperform | ¥214.81B | 14.50 | 6.87% | 5.25% | -1.43% | 171.44% | |
67 Neutral | ¥181.24B | 11.58 | 5.06% | 1.80% | 4.10% | 152.90% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |